
An Indian court has stopped the sale of Ranbaxy Laboratories to Sun Pharmaceutical Industries after concerns were raised over insider …

Sun Pharmaceutical Industries has bought struggling drugmaker Ranbaxy Laboratories in a deal that will see the two companies become the …

GlaxoSmithKline’s manufacturing woes are getting worse after the firm was hit with a second FDA warning in as many days. …

The FDA has warned GlaxoSmithKline that the US importation of products from the firm’s facility in Cork, Ireland could be …

Icon has acquired US clinical trial specialists Aptiv Solutions for $143.5 million as it looks to expand its footprint in …
Biopharma services provider Parexel International Corporation is beefing up its global capacity and adding more secondary packaging and labelling services …

The $2.65 billion merger between Patheon and DSM’s pharma business has completed, creating a new privately-held company called DPx. The …

The reputation of India’s pharma sector has been dealt a further blow after yet another drugmaker was placed under an …

India’s largest native generic drugmaker Ranbaxy has come under greater pressure this week after the US has again sent out …

The FDA is planning to introduce a new digital resource in order to open up its data to the public …

The FDA has refused to approve a new diabetes treatment from Lilly and its partner Boehringer Ingelheim due to ongoing …

Yet another plant operated by India’s Ranbaxy has been held up by US Food and Drug Administration over quality deficiencies, …
GlaxoSmithKline has launched a new website and Twitter account to inform the public about progress with its £350 million ($574 …

The regulatory authorities in the US and EU have taken another step towards harmonisation by agreeing to pool their resources …

Novartis is shutting down its manufacturing plant in Canada which will result in 300 people losing their jobs at the …